Search Tag: Hologic
Visit-hologic-at-the-virtual-ecr-congress-2020
2020 14 Jul
“MUST SEE” Attractions at ECR 2020, 15-21 July, Virtual Event Discover how Hologic’s clinically proven, integrated solutions incorporating AI can support you managing your patients across the breast health continuum of care in our virtual booth. From screening to monitoring, our leading innovations support you in delivering excellence in...Read more
Ce-mark-for-localizer-implantable-tag-extended-for-long-term-placement-in-breast-lesions
2019 26 Nov
Wire-free lesion localization tags can now be implanted for more than 30 days, creating greater flexibility for providers and patients during breast-conserving surgeries Hologic today announced the extension of the CE Mark for its LOCalizer™ radiofrequency identification (RFID) tag for long-term placement. The tag can now be implanted more than...Read more
Hologic-showcases-new-breast-surgery-franchise-at-20th-annual-meeting-of-asbr
2019 30 Apr
Breast health leader will highlight expanding portfolio for breast conserving surgery Hologic, Inc. will showcase its growing breast surgery franchise, which includes products such as the new Trident® HD specimen radiography system, LOCalizer™ wire-free guidance system and the BioZorb® marker, in Booth #103 at the 20th Annual Meeting of...Read more
Hologic-launches-trident-r-hd-specimen-radiography-system-in-united-states-canada-and-europe
2019 26 Apr
Company expands breast specimen imaging portfolio and leadership in breast cancer diagnosis and care. Hologic, Inc. today announced global commercial availability of the Trident ® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow and instant sample verification during...Read more
Hologic-receives-health-canada-medical-device-license-for-three-in-one-omni-hysteroscope
2019 21 Mar
Flexible, modular design with powerful visualisation gives doctors a single device with three sheath options to both diagnose and treat patients MARLBOROUGH, Mass., March 4, 2019 -- Hologic, Inc. (Nasdaq: HOLX) announced today that Health Canada has issued a medical device license for its Omni™ hysteroscope , an innovative three-in-one...Read more
Hologic-receives-ce-mark-for-three-in-one-omni-hysteroscope-in-europe
2019 21 Mar
Flexible, modular design with powerful visualisation gives doctors a single device with three sheath options to both diagnose and treat patients MARLBOROUGH, Mass.-- Hologic, Inc. (Nasdaq: HOLX) announced today that it has received a CE mark in Europe for its Omni™ hysteroscope , an innovative three-in-one modular scope with advanced visualization...Read more
Hologic-opens-state-of-the-art-learning-and-experience-centre-in-zaventem-belgium
2019 21 Mar
Women’s health company offers new training facility for partners, healthcare professionals and employees Hologic, Inc ., an innovative medical technology company focused on improving women’s health and well-being through early detection and treatment, today opened its first Learning and Experience Centre in Zaventem, Belgium (a municipality...Read more
Hologic-announces-european-ce-mark-for-localizer-wireless-breast-lesion-localization-system
2019 28 Feb
Latest addition to growing portfolio of breast and skeletal health innovations to be featured at ECR 2019 Hologic announced today the granting of a CE Mark to the LOCalizer™ wireless radio frequency identification (RFID) breast lesion localization system. This system is designed for precise and easy marking and targeting...Read more
A-patient-centred-approach-to-mammography-1
2018 22 Sep
Head radiologist provides feedback on department’s three-year use of the Hologic Selenia® Dimensions® 3D Mammography™ System In an exclusive interview with HealthManagement, Dr. Annie Philippou Papoutsou explains how the implementation of Hologic’s Selenia® Dimensions® 3D Mammography™ System has helped radiologists to detect more cancers,...Read more
A-patient-centred-approach-to-mammography
2018 25 Jul
Head radiologist provides feedback on department’s three-year use of the Hologic Selenia® Dimensions® 3D Mammography™ System In an exclusive interview with HealthManagement.org, Dr. Annie Philippou Papoutsou explains how the implementation of Hologic’s Selenia® Dimensions® 3D Mammography™ System has helped radiologists to detect more cancers,...Read more
Premier-inc-celebrates-a-decade-of-showcasing-the-latest-medical-innovations-at-annual-conference
2018 20 Jun
Premier Inc., a leading healthcare improvement company, celebrated a decade of showcasing innovative products during its Innovation Celebration last night. The annual event honors supplier commitment to industry-leading healthcare advancements. “We are so proud to have been able to spotlight dozens of ground-breaking products over the past decade”...Read more
Hologic-announces-financial-results-for-second-quarter-of-fiscal-2018
2018 03 May
-- Revenue of $789.3 Million Grows 10.3%, 8.3% in Constant Currency -- -- Company Posts GAAP Diluted EPS of ($2.46) Due to Non-Cash Charges, Non-GAAP Diluted EPS of $0.53 – Hologic, Inc. has announced the Company's financial results for the fiscal second quarter ended March 31, 2018 . Revenue of $789.3 million increased 10.3%, or 8.3%...Read more
Philips-and-hologic-announce-global-partnership-to-provide-integrated-imaging-solutions-for-women
2018 02 Mar
Royal Philips , a global leader in health technology, and Hologic, Inc. , an innovative women's health company, announced today a global partnership agreement to offer care professionals integrated solutions comprising diagnostic imaging modalities, advanced informatics and services for screening, diagnosis and treatment of women across the world....Read more
Hologic-launches-fluoroscan-r-insight-fd-mini-c-arm-extremities-imaging-system
2018 26 Jan
Hologic, Inc. today announced the launch of the next generation in mini C-arm imaging, the Fluoroscan® InSight™ FD Mini C-Arm, the latest product illustrating the Company’s commitment to addressing the continuum of skeletal health care. The enhanced system adds to Hologic’s portfolio of market-leading skeletal imaging solutions. It offers...Read more
Hologic-announces-european-ce-mark-for-brevera-r-breast-biopsy-system-with-corlumina-r
2018 09 Jan
Transformational Workflow Solution Offers Real-Time Imaging of Tissue Samples, Resulting in Major Cost and Time Savings Hologic, Inc. today announced it has obtained a CE Mark in Europe for the Brevera® breast biopsy system with CorLumina® imaging technology, a groundbreaking real-time breast biopsy and verification system that improves...Read more
Hologic-selected-for-dutch-breast-cancer-screening-program
2017 02 Nov
Under the tender, state-of-the-art 3DimensionsTM mammography systems will be installed starting in 2018 Hologic, Inc. has announced that it will provide all mammography systems for the Dutch Breast Cancer Screening Program in partnership with Tromp Medical, Hologic’s distributor in the Netherlands. Under the tender, Hologic’s new, state-of-the-art...Read more
Reinventing-breast-tomosynthesis
2017 30 Oct
Expanding leadership based on clinical evidence In early September, Hologic launched the new 3Dimensions™ mammography system , a breast tomosynthesis system with the fastest and highest resolution, in EMEA. I recently had the pleasure of showcasing this cutting-edge device at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting,...Read more
Paraflu-assay-fda-cleared-on-hologics-panther-fusion-r-system
2017 26 Oct
-- New Assay Extends Respiratory Testing Menu; Modular Panels and Fusion System Increase Efficiency and Flexibility for the Laboratory – Hologic, Inc. announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Panther Fusion® Paraflu assay, a multiplexed assay which runs...Read more
Hologic-receives-ce-mark-to-market-sculpsure-r-for-non-invasive-body-contouring-of-the-submental-area
2017 19 Oct
Patients in Clinical Studies Report 100% Satisfaction Hologic, Inc. has announced that it has received an additional European Medical Device Directive (MDD) certification for SculpSure®, a state-of-the-art body contouring laser treatment. The device is now certified to treat a double chin (also known as the submental area), marking the product's...Read more
Panther-fusion-r-flu-assay-fda-cleared-on-hologics-panther-fusion-r
2017 06 Oct
- New Panther Fusion Module Expands System's Molecular Testing Capabilities, Increases Efficiency and Flexibility for the Laboratory Hologic, Inc. has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Panther Fusion® Flu A/B/RSV assay running on the new Panther Fusion®...Read more
Hologic-enters-into-amended-and-restated-five-year-secured-credit-agreement
2017 04 Oct
- Initial Proceeds from New $1.5 Billion Term Loan and $1.5 Billion Revolving Credit Line Used to Refinance Senior Secured Debt - - Funds Also Expected to Contribute to Retirement of Remaining Convertible Notes - Hologic, Inc.has announced that the Company has entered into an amended and restated credit agreement consisting of a new, five-year $1.5...Read more
Hologic-announces-offering-of-350-million-of-senior-notes-due-2025
2017 04 Oct
- Proceeds Expected to Contribute to Retirement of Remaining Convertible Notes - Hologic, Inc. has announced that it has launched, subject to market and other conditions, a private offering of $350 million aggregate principal amount of senior notes due 2025. Hologic intends to use the proceeds of the offering and available cash,...Read more
Hologic-announces-q4-2017-financial-results
2017 03 Oct
Hologic, Inc. has announced that the Company plans to release its financial results for the fourth quarter of fiscal 2017 on Wednesday, November 8, 2017 after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by...Read more
Hologic-ceo-steve-macmillan-to-ring-nasdaq-opening-bell-to-kick-off-breast-cancer-awareness-month
2017 30 Sep
Trailblazing Company Behind the Genius™ 3D Mammography™ Exam Celebrates Year of Innovations in Breast Health Hologic, Inc. has announced that Steve MacMillan, the Company's Chairman, President and Chief Executive Officer, will join selected employees to ring the Nasdaq Opening Bell on October 2 in conjunction with the start of Breast Cancer...Read more
Hologic-receives-fda-510-k-clearance-to-market-sculpsure-r-for-non-invasive-body-contouring
2017 30 Sep
Patients in Clinical Studies Report 100% Satisfaction Rate Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded FDA 510(k) clearance for Cynosure's non-invasive body contouring product, SculpSure ®. The state-of-the-art body contouring laser treatment is now cleared to treat a double chin (also...Read more
Hologic-introduces-a-more-comfortable-mammogram
2017 27 Sep
93% of Women Surveyed Reported Improved Comfort with the New System* Hologic, Inc . has announced the commercial availability of its new SmartCurve™ breast stabilization system, which has been clinically proven to deliver a more comfortable mammogram without compromising image quality, workflow or dose. 1 The SmartCurve system is available...Read more
Hologic-s-3dimensions-mammography-system-now-available-in-europe
2017 12 Sep
Fastest, Highest Resolution Breast Tomosynthesis System is Designed to Increase Clinical Confidence, Accuracy and Patient Comfort Hologic, Inc . has announced that the 3Dimensions ™ mammography system, the fastest, highest resolution breast tomosynthesis system ever, is available for purchase in Europe. [1] The new product is the latest...Read more
Hologic-announces-availability-of-new-brevera-r-breast-biopsy-system
2017 31 Aug
Transformational Workflow Solution Offers Real-Time Imaging of Tissue Samples, Resulting in Major Cost and Time Savings Hologic, Inc. has announced U.S. commercial availability of the Brevera® breast biopsy system with CorLumina®imaging technology, a groundbreaking real-time breast biopsy and verification system that enhances workflow, improves...Read more
Hologic-announces-financial-results-for-third-quarter-of-fiscal-2017
2017 03 Aug
-- Company Posts Revenue of $806.1 Million, GAAP Diluted EPS of $0.21, and Non-GAAP Diluted EPS of $0.50 -- -- Organic Revenue Growth Led by Molecular Diagnostics and International Businesses -- Hologic, Inc. has announced the Company's financial results for the fiscal third quarter ended July 1, 2017 . GAAP diluted earnings per share (EPS)...Read more
Hologic-to-webcast-presentations-at-upcoming-investor-conferences-6
2017 31 Jul
Hologic, Inc. has announced that the Company will present at these upcoming investor conferences: The Canaccord Genuity Growth Conference in Boston, MA on Wednesday, August 9 at 4 p.m. Eastern Time (ET). Morgan Stanley's 15th Annual Global Healthcare Conference in New York, NY on Monday, September 11 at 9:55 a.m. ET . Each prRead more